This important meeting, held at the John McIntyre Centre in Edinburgh on 7/8 October 2019, is brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.
Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.
Across two days, we will discuss how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We will also look at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.
This meeting will be of particular interest to pharmacologists, those working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, will also be joining our panel discussions.
Hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan and our key note speaker, Jane Lebkowski.
This meeting will feature both oral communication and poster presentations. Please submit an abstract for the meeting before the deadline, 19 July 2019.
If you have any questions about the abstract submission process, please email email@example.com.